Vaccine · BLA
Menveo NDC 58160-827
Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen 10 ug/.5mL + 3 more ingredients · Injection, Solution · Intramuscular · GlaxoSmithKline Biologicals SA
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 58160-827-30 | 5816008273058160082730 | 10 VIAL in 1 CARTON (58160-827-30) / .5 mL in 1 VIAL (58160-827-03)Marketed from Dec 9, 2022 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Menveo
- Generic name (nonproprietary)
- meningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine
- Active ingredients
- Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen — 10 ug/.5mLNeisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen — 5 ug/.5mLNeisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen — 5 ug/.5mLNeisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen — 5 ug/.5mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular
- Labeler
- GlaxoSmithKline Biologicals SANDC labeler code 58160
- Product type
- Vaccine
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 125300
- Marketing start
- Listing expires
- Other FDA classes
- Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Actively Acquired Immunity (Physiologic effect)Meningococcal Vaccines (Chemical structure)Meningococcal Vaccines (Chemical structure)Meningococcal Vaccines (Chemical structure)Meningococcal Vaccines (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)Inactivated (Chemical structure)
- Identifiers
- Product ID 58160-827_1d7345ef-44b1-4d00-9bde-2614d3510c19SPL ID 1d7345ef-44b1-4d00-9bde-2614d3510c19
- Pharmacologic class
- Inactivated Meningococcal Vaccine
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Immunization administration (CPT 90460–90474)
Giving a vaccine is reported separately from the vaccine product code, with an immunization administration code. Which code applies depends on the patient's age, the route and whether counselling was provided.
- NDC on a medical claim
N458160082730followed by a unit qualifier and the quantityPackage 58160-0827-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
The FDA listing for this product does not reference a label (SPL) set.
About NDC 58160-827
- What is NDC 58160-827?
- 58160-827 is the product NDC for Menveo, Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen 10 ug/.5mL + 3 more ingredients injection, solution, listed with the FDA by GlaxoSmithKline Biologicals SA. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine).
- What is the active ingredient?
- Neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group c capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group w-135 capsular oligosaccharide diphtheria crm197 protein conjugate antigen, Neisseria meningitidis group y capsular oligosaccharide diphtheria crm197 protein conjugate antigen.
- Who is the labeler?
- GlaxoSmithKline Biologicals SA, NDC labeler code 58160. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Menveo?
- 1 other product NDC are listed under this name. See all Menveo NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Menveo products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Menveomeningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine | — | Kit | GlaxoSmithKline Biologicals SA | 58160-955 | 58160-0955-09 |
Other NDCs under BLA 125300
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Menveomeningococcal (groups a, c, y and w-135) oligosaccharide diphtheria crm197 conjugate vaccine | — | Kit | GlaxoSmithKline Biologicals SA | 58160-955 |